This document contains the release notes for IBM App Connect for Healthcare V5.0, including the tooling and runtime components.
Product Release: 5.0
Update name: 22.214.171.124
Versions and fix packs:
* V126.96.36.199 (electronic availability: 31 March 2020)
Document first published: 31 March 2020
Document last modified: 1 July 2020
- Download location
- Installation information:
- Additional information
- Known problems and their workarounds (if any)
- Copyright and trademark information
- Useful websites
Download IBM App Connect for Healthcare V5.0 by using the following instructions:
Installation information is available in the IBM App Connect for Healthcare product documentation at:
The online product documentation for IBM App Connect for Healthcare is available at:
Defects: This release notes file might contain references to defect numbers. These numbers refer to internal IBM problem numbers; you might find these numbers useful when discussing problems with your IBM service representative.
Technotes: For current information about known problems and available fixes, see the IBM App Connect Enterprise support website at:
Versions: For the latest information about which versions of operating systems are supported by IBM App Connect for Healthcare, see the system requirements page at:
Check periodically for updates to the toolkit, including documentation updates. Recommended fixes for IBM App Connect for Healthcare can be found at:
Known problems and their workarounds (if any)
This section outlines the known problems and their workarounds (if any) of IBM App Connect for Healthcare, by component.
This information was developed for products and services offered in the U.S.A.
IBM may not offer the products, services, or features discussed in this information in other countries. Consult your local IBM representative for information on the products and services currently available in your area. Any reference to an IBM product, program, or service is not intended to state or imply that only that IBM product, program, or service may be used. Any functionally equivalent product, program, or service that does not infringe any IBM intellectual property right may be used instead. However, it is the user's responsibility to evaluate and verify the operation of any non-IBM product, program, or service.
IBM may have patents or pending patent applications covering subject matter described in this information. The furnishing of this information does not give you any license to these patents. You can send license inquiries, in writing, to:
- IBM Director of Licensing
North Castle Drive
Armonk, NY 10504-1785
For license inquiries regarding double-byte character set (DBCS) information, contact the IBM Intellectual Property Department in your country or send inquiries, in writing, to:
- IBM World Trade Asia Corporation
2-31 Roppongi 3-chome, Minato-ku
Tokyo 106, Japan
The following paragraph does not apply to the United Kingdom or any other country where such provisions are inconsistent with local law:
INTERNATIONAL BUSINESS MACHINES CORPORATION PROVIDES THIS PUBLICATION "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF NON-INFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Some states do not allow disclaimer of express or implied warranties in certain transactions, therefore, this statement may not apply to you.
This information could include technical inaccuracies or typographical errors. Changes are periodically made to the information herein; these changes will be incorporated in new editions of the information. IBM may make improvements and/or changes in the product(s) and/or the program(s) described in this information at any time without notice.
Any references in this information to non-IBM Web sites are provided for convenience only and do not in any manner serve as an endorsement of those Web sites. The materials at those Web sites are not part of the materials for this IBM product and use of those Web sites is at your own risk.
IBM may use or distribute any of the information you supply in any way it believes appropriate without incurring any obligation to you.
Licensees of this program who wish to have information about it for the purpose of enabling: (i) the exchange of information between independently created programs and other programs (including this one) and (ii) the mutual use of the information which has been exchanged, should contact:
- IBM United Kingdom Laboratories,
Mail Point 151,
Such information may be available, subject to appropriate terms and conditions, including in some cases, payment of a fee.
The licensed program described in this information and all licensed material available for it are provided by IBM under terms of the IBM Customer Agreement, IBM International Programming License Agreement, or any equivalent agreement between us.
Information concerning non-IBM products was obtained from the suppliers of those products, their published announcements or other publicly available sources. IBM has not tested those products and cannot confirm the accuracy of performance, compatibility or any other claims related to non-IBM products. Questions on the capabilities of non-IBM products should be addressed to the suppliers of those products.
This information includes examples of data and reports used in daily business operations. To illustrate them as completely as possible, the examples include the names of individuals, companies, brands, and products. All of these names are fictitious and any similarity to the names and addresses used by an actual business enterprise is entirely coincidental.
This information contains sample application programs in source language, which illustrate programming techniques on various operating platforms. You may copy, modify, and distribute these sample programs in any form without payment to IBM, for the purposes of developing, using, marketing or distributing application programs conforming to the application programming interface for the operating platform for which the sample programs are written. These examples have not been thoroughly tested under all conditions. IBM, therefore, cannot guarantee or imply reliability, serviceability, or function of these programs. You may copy, modify, and distribute these sample programs in any form without payment to IBM for the purposes of developing, using, marketing, or distributing application programs conforming to IBM's application programming interfaces.
The following terms are trademarks of International Business Machines Corporation in the United States, other countries, or both:
AIX, developerWorks, IBM, Passport Advantage, WebSphere.
Java and all Java-based trademarks and logos are trademarks or registered trademarks of Oracle and/or its affiliates in the United States, other countries, or both
Microsoft and Windows are trademarks of Microsoft Corporation in the United States, other countries, or both.
UNIX is a registered trademark of The Open Group in the United States and other countries.
Linux is a trademark of Linus Torvalds in the United States, other countries, or both.
FHIR is the registered trademark of HL7 and is used with the permission of HL7. Use of the FHIR trademark does not constitute endorsement of this product by HL7.
Other company, product or service names might be trademarks or service marks of others.
IBM App Connect Enterprise product page
IBM MQ Fix Packs
IBM App Connect Enterprise Fix Packs
IBM App Connect Enterprise Requirements
IBM App Connect for Healthcare V5.0 online product documentation
IBM Centre for Java™ Technology Development Downloads
Original Publication Date
31 March 2020
01 July 2020